latestnewsandupdates5m
Viking’s new anti-obesity pill costs too much to mass-produce
The pharmaceutical company Viking has recently become one of the most volatile stocks on Wall Street due to the announcement ...
The Globe and Mail39m
Stocks Under Pressure Ahead of Tuesday’s Election and FOMC Meeting
Viking Therapeutics (VKTX) is up more than +5% after the company’s experimental pill, VK2735, showed weight loss in patients at higher doses with limited side effects. Air Transport Services Group ...